Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CDTX

Cidara Therapeutics Inc

Nov 14 • 04:00PM ET

217.71

+111.72 105.41 %

Healthcare • Biotechnology • USA • NASD

Peers: JNJ GILD REGN PFE AMGN MRNA VRTX BMY SNY BIIB

| Held by: VTI XBI IWM VXF IWN DWAS PINK SCHA FYC VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-11.78	Insider Own	24.02%	Shs Outstand	29.34M	Perf Week	108.55%
Market Cap	6.84B	Forward P/E	-	EPS next Y	-6.44	Insider Trans	43.13%	Shs Float	23.89M	Perf Month	113.40%
Enterprise Value	6.42B	PEG	-	EPS next Q	-1.62	Inst Own	85.42%	Short Float	13.41%	Perf Quarter	244.26%
Income	-184.74M	P/S	-	EPS this Y	71.87%	Inst Trans	66.39%	Short Ratio	3.69	Perf Half Y	753.76%
Sales	0.00M	P/B	15.12	EPS next Y	14.47%	ROA	-54.27%	Short Interest	3.20M	Perf YTD	709.93%
Book/sh	14.40	P/C	16.05	EPS next 5Y	38.28%	ROE	-68.70%	52W High	121.21 79.61%	Perf Year	1518.66%
Cash/sh	13.56	P/FCF	-	EPS past 3/5Y	-17.79% 1.30%	ROIC	-43.69%	52W Low	13.82 1475.33%	Perf 3Y	1863.47%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-70.48% -42.85%	Gross Margin	-	Volatility	4.51% 5.96%	Perf 5Y	369.20%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	53.89%	Oper. Margin	-	ATR (14)	13.95	Perf 10Y	-25.85%
Dividend Ex-Date	-	Quick Ratio	4.62	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	88.71	Recom	1.89
Dividend Gr. 3/5Y	- -	Current Ratio	4.62	EPS Q/Q	-26.48%	SMA20	100.93%	Beta	1.56	Target Price	188.86
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	127.73%	Rel Volume	19.93	Prev Close	105.99
Employees	38	LT Debt/Eq	0.00	Earnings	Nov 06 AMC	SMA200	335.09%	Avg Volume	867.49K	Price	217.71
IPO	Apr 15, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	-131.91% -	Trades		Volume	17,287,359	Change	105.41%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-16-25	Initiated	Morgan Stanley	Overweight	$190
Oct-10-25	Initiated	JP Morgan	Overweight	$200
Jun-18-25	Resumed	H.C. Wainwright	Buy	$41
Mar-12-25	Initiated	Citizens JMP	Mkt Outperform	$46
Jan-27-25	Resumed	Cantor Fitzgerald	Overweight
Dec-13-24	Initiated	RBC Capital Mkts	Outperform	$34
Nov-08-24	Initiated	Guggenheim	Buy	$33
Aug-14-24	Upgrade	H.C. Wainwright	Neutral → Buy	$24
Dec-03-21	Resumed	H.C. Wainwright	Buy	$6
Sep-22-21	Upgrade	WBB Securities	Buy → Strong Buy	$6.25
Mar-04-21	Initiated	Aegis Capital	Buy	$9
Sep-04-19	Upgrade	Wedbush	Neutral → Outperform	$2 → $4
Jul-26-18	Initiated	Citigroup	Buy	$8
Apr-21-17	Initiated	Raymond James	Strong Buy
Apr-17-17	Reiterated	H.C. Wainwright	Buy	$18 → $14
Apr-12-17	Initiated	Ladenburg Thalmann	Buy	$11.25
Apr-11-17	Resumed	Wedbush	Outperform	$13
Feb-22-17	Upgrade	WBB Securities	Sell → Hold	$7.25
Feb-22-17	Reiterated	H.C. Wainwright	Buy	$25 → $18
Dec-21-16	Resumed	Leerink Partners	Outperform

Show Previous Ratings

Nov-15-25 07:06AM	Cidara Therapeutics (CDTX) Skyrockets 105% on Merck $9.2-Billion Acquisition Bid (Insider Monkey)
Nov-14-25 03:53PM	This Biotech's Stock Price More Than Doubled on Friday. Here's Why. (Investopedia) +105.41%
03:19PM	Halper Sadeh LLC Encourages CDTX, MRSN, HOLX Shareholders to Contact the Firm to Discuss Their Rights (PR Newswire)
12:39PM	Health Care Roundup: Market Talk (The Wall Street Journal)
12:34PM	Top Stock Movers Now: StubHub, DoorDash, Netflix, and More (Investopedia)
12:19PM	Loading…
12:19PM	Merck Swoops In On Buyout Bonanza With A $9.2 Billion Cidara Therapeutics Deal (Investor's Business Daily)
12:06PM	Merck to buy Cidara for $9.2B, Netflix nears 10-for-1 stock split (Yahoo Finance Video)
11:35AM	Stocks to Watch Friday: Walmart, Eli Lilly, Warner Bros. (The Wall Street Journal)
11:30AM	Merck Is Paying Up for Flu Biotech as M&A Spree Continues (Barrons.com)
11:23AM	MSD bets big on flu antivirals with $9.2bn buyout of Cidara (Pharmaceutical Technology)
11:20AM	This is why Merck is buying Cidara Therapeutics for $9.2 billion, and why Wall Street is happy (MarketWatch)
10:47AM	WBD amends CEO Zaslav's contract, StubHub withholds Q4 guidance (Yahoo Finance Video)
09:48AM	Stocks to Watch Friday: Walmart, Cidara, Warner Bros. (The Wall Street Journal)
09:37AM	Merck agrees $9.2bn deal for flu-prevention biotech Cidara (Financial Times)
08:19AM	This Biotech Stock Is Soaring 100%. Merck Is Buying It. (Barrons.com)
07:16AM	Loading…
07:16AM	Merck to Buy Cidara Therapeutics in $9.2 Billion Deal (The Wall Street Journal)
06:45AM	Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent (Business Wire)
06:36AM	Applied Materials shares drop after results, and other early market movers (MarketWatch)
Nov-08-25 10:00AM	Cidara Therapeutics Inc (CDTX) Q3 2025 Earnings Call Highlights: Advancements in CD 388 and ... (GuruFocus.com)
Nov-06-25 04:14PM	Cidara Therapeutics: Q3 Earnings Snapshot (Associated Press Finance) +5.83%
04:07PM	Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-04-25 07:31AM	What Makes Cidara Therapeutics (CDTX) an Investment Bet? (Insider Monkey)
Oct-28-25 08:00AM	Cidara Therapeutics to Participate in November Investor Conferences (GlobeNewswire) +5.16%
Oct-23-25 04:05PM	Cidara Therapeutics to Report Third Quarter 2025 Financial Results and Host Quarterly Conference Call on November 6, 2025 (GlobeNewswire)
08:00AM	Cidara Therapeutics Announces Late-Breaking Presentation on CD388 at 10?? ESWI Influenza Conference 2025 (GlobeNewswire)
Oct-21-25 08:00AM	Cidara Therapeutics Announces Late-Breaking Phase 2b Data Presentation on CD388 at ID Week 2025 (GlobeNewswire)
Oct-19-25 03:09AM	Morgan Stanley Initiates Cidara Therapeutics (CDTX) With a Buy (Insider Monkey)
Oct-16-25 04:33PM	FDA Grants Cidara Therapeutics' CD388 Breakthrough Therapy Designation for Flu Prevention in High-Risk Patients (Insider Monkey)
Oct-13-25 08:00AM	Cidara Therapeutics to Present Late-Breaking Clinical Phase 2 Data on CD388 at ID Week 2025 (GlobeNewswire)
Oct-10-25 12:21PM	CDTX Stock Up on FDA's Breakthrough Therapy Tag for CD388 in Influenza (Zacks)
09:36AM	Loading…
09:36AM	Align downgraded, NetEase upgraded: Wall Street's top analyst calls (The Fly)
08:00AM	Cidara Therapeutics to Present at 10th ESWI Influenza Conference 2025 (GlobeNewswire)
Oct-09-25 06:32PM	Why Cidara Therapeutics Stock Crushed It Today (Motley Fool) +12.44%
08:00AM	Cidara Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for CD388 in Seasonal Influenza Prevention (GlobeNewswire)
Oct-02-25 04:01PM	Cidara Therapeutics Announces BARDA Award to Support Expanded Manufacturing and Clinical Development of CD388, its Non-Vaccine Influenza Preventative Therapeutic (GlobeNewswire)
Sep-30-25 12:46PM	Cidara Therapeutics, Inc. (CDTX) Accelerates Phase 3 Trial for Single-Dose Flu Antiviral CD388 (Insider Monkey)
Sep-26-25 05:09PM	Why Cidara Therapeutics Was Such a Healthy Stock Today (Motley Fool) +6.77% +5.27%
10:05AM	CDTX Stock Soars 218% YTD on Positive Updates From Influenza Program (Zacks)
Sep-25-25 04:01PM	Cidara Therapeutics Announces First Participants Dosed in Phase 3 ANCHOR Trial Evaluating CD388 for the Prevention of Seasonal Influenza in High-Risk Populations (GlobeNewswire)
Sep-24-25 04:18PM	Why Cidara Therapeutics, Already Up 173% This Year, Just Hit A Seven-Year High (Investor's Business Daily) +20.53%
10:56AM	Why Cidara Therapeutics, Already Up 173% This Year, Just Hit A Five-Year High (Investor's Business Daily)
07:00AM	Cidara Therapeutics Announces Expanded and Accelerated Phase 3 Plan for CD388, a Non-Vaccine Preventative of Seasonal Influenza (GlobeNewswire)
Sep-22-25 12:00PM	Cidara Therapeutics (CDTX) Upgraded to Buy: Here's What You Should Know (Zacks) +9.84%
09:40AM	Has Black Diamond Therapeutics (BDTX) Outpaced Other Medical Stocks This Year? (Zacks)
Sep-17-25 08:00AM	Cidara Therapeutics Presents Data on CD388 from its Phase 2b NAVIGATE Trial and Preclinical Studies Against H5N1 at ISRV's 8th AVG and 3rd IMRP 2025 Meeting (GlobeNewswire)
Sep-04-25 08:00AM	Cidara Therapeutics to Participate in September Investor Conferences (GlobeNewswire)
Sep-03-25 08:00AM	Cidara Therapeutics to Present Clinical Phase 2b Data and Preclinical H5N1 Data on CD388 at ISRV's 8th AVG and 3rd IMRP 2025 Meeting (GlobeNewswire)
Aug-08-25 03:38AM	Cidara Therapeutics Inc (CDTX) Q2 2025 Earnings Call Highlights: Promising Clinical Trial ... (GuruFocus.com)
Aug-07-25 05:17PM	Cidara Therapeutics: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-24-25 08:00AM	Cidara Therapeutics to Report Second Quarter 2025 Financial Results and Host Quarterly Conference Call on August 7, 2025 (GlobeNewswire)
Jul-03-25 04:06PM	Warner Bros., Cidara, LENZ Therapeutics, and More Stocks See Action From Activist Investors (Barrons.com)
Jul-01-25 04:59PM	Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire)
Jun-30-25 02:21PM	Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains (MarketBeat)
08:00AM	Cidara Therapeutics Announces Inclusion in the Russell 2000 and Russell 3000 Indexes (GlobeNewswire)
Jun-26-25 05:15PM	Cidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
Jun-24-25 08:00PM	Cidara Announces Pricing of Upsized Public Offering of Common Stock (GlobeNewswire) +5.32%
Jun-23-25 04:25PM	Cidara Therapeutics Doubles As A Universal Flu Shot Becomes A Closer Reality (Investor's Business Daily) +113.84%
04:15PM	Cidara Announces Proposed Public Offering of Common Stock (GlobeNewswire)
11:20AM	Cidara Launches 93% As A Universal Flu Shot Becomes A Closer Reality (Investor's Business Daily)
08:27AM	Cidara stock soars as antiviral drug succeeds in flu study (BioPharma Dive)
07:00AM	Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza (GlobeNewswire)
May-15-25 08:00AM	Cidara Therapeutics to Host Virtual R&D Day to Discuss CD388 as a Potential Universal, Once-Per-Flu Season Preventative of Seasonal and Pandemic Influenza on May 22, 2025 (GlobeNewswire) +8.99%
May-13-25 08:00AM	Cidara Therapeutics to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
May-09-25 03:48AM	Cidara Therapeutics Inc (CDTX) Q1 2025 Earnings Call Highlights: Promising Advances in ... (GuruFocus.com)
May-08-25 04:38PM	Cidara Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-05-25 05:00AM	Cidara Therapeutics: Strong Buy On Imminent Data Readout For Lead Flu Candidate (Seeking Alpha)
May-01-25 08:00AM	Cidara Therapeutics Announces Promotion of Nicole Davarpanah to Chief Medical Officer and Corrina Pavetto to SVP, Clinical Development (GlobeNewswire)
Apr-30-25 12:00PM	Are You Looking for a Top Momentum Pick? Why Cidara Therapeutics (CDTX) is a Great Choice (Zacks)
08:00AM	Cidara Therapeutics to Participate in The Citizens Life Sciences Conference (GlobeNewswire)
Apr-24-25 08:00AM	Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025 (GlobeNewswire)
Apr-16-25 08:00AM	Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors (GlobeNewswire)
Apr-01-25 04:56PM	Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire) -12.16%
04:05PM	Cidara Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-21-25 09:55AM	Wall Street Analysts Predict a 64.5% Upside in Cidara Therapeutics (CDTX): Here's What You Should Know (Zacks)
Mar-19-25 08:12AM	Cidara Therapeutics to present on CD388 at ICAR 2025 (TipRanks)
08:00AM	Cidara Therapeutics to Participate in World Health Organization Meeting on H5N1 Influenza Preparedness and Response (GlobeNewswire)
Mar-18-25 08:00AM	Cidara Therapeutics Announces Two Presentations on CD388 in Influenza at International Conference on Antiviral Research (ICAR) 2025 (GlobeNewswire)
Mar-17-25 06:00AM	Cidara Therapeutics Announces Publication of CD388 Preclinical Data in Nature Microbiology (GlobeNewswire)
Mar-06-25 05:03PM	Cidara Therapeutics: Q4 Earnings Snapshot (Associated Press Finance)
04:35PM	Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-18-25 04:15PM	Cidara Therapeutics Announces Appointment of Frank Karbe as Chief Financial Officer (GlobeNewswire)
Jan-30-25 04:05PM	Cidara Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference (GlobeNewswire)
Jan-13-25 03:37PM	Here's Why Cidara Therapeutics, Inc. (CDTX) Is Skyrocketing (Insider Monkey) -11.71%
Dec-05-24 11:07AM	Cidara achieves full enrolment in influenza prevention trial (Clinical Trials Arena)
Dec-04-24 08:00AM	Cidara Therapeutics Completes Enrollment of Phase 2b NAVIGATE Trial Evaluating CD388 for Prevention of Seasonal Influenza (GlobeNewswire) +12.65%
Dec-03-24 09:55AM	Cidara Therapeutics (CDTX) Just Flashed Golden Cross Signal: Do You Buy? (Zacks) -5.60%
Nov-21-24 08:30AM	Cidara Therapeutics Announces $105 Million Private Placement (GlobeNewswire) +15.41%
Nov-19-24 08:00AM	Cidara Therapeutics to Participate in Evercore 7th Annual HealthCONx Conference (GlobeNewswire)
Nov-07-24 05:09PM	Cidara Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-31-24 08:00AM	Cidara Therapeutics to Participate in Two Upcoming November Investor Conferences (GlobeNewswire)
Oct-16-24 08:00AM	Cidara Therapeutics Announces Two Presentations on Drug-Fc Conjugate, CD388, at IDWeek 2024 (GlobeNewswire) +5.60%
Oct-04-24 04:30PM	Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire)
Sep-25-24 08:00AM	Cidara Therapeutics Announces Two Presentations on Innovative Drug-Fc Conjugate, CD388, at the 2024 OPTIONS XII for the Control of Influenza Conference (GlobeNewswire)
Sep-23-24 08:00AM	Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza (GlobeNewswire)
Sep-19-24 08:00AM	Cidara Therapeutics Strengthens its Scientific Advisory Board with Infectious Disease Experts (GlobeNewswire)
Sep-13-24 10:13AM	Cidara axes 30% of staff to focus on flu prevention drug (Pharmaceutical Technology) +5.20%
07:53AM	Cidara buys back rights to flu therapy from J&J for $85m (Pharmaceutical Technology)

Cidara Therapeutics, Inc. engages in developing targeted immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases. Its platform, Cloudbreak, enables development of novel drug-Fc conjugates (DFCs) that inhibit specific disease targets while simultaneously engaging the immune system. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Davarpanah Nicole Negar	Chief Medical Officer	Sep 11 '25	Sale	62.86	474	29,797	31,418	Sep 15 07:05 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Jun 26 '25	Buy	44.00	2,272,727	99,999,988	3,365,523	Jun 30 04:56 PM
Mineo Chrysa	Director	Jun 02 '25	Buy	21.71	2,270	49,281	2,270	Jun 04 04:23 PM
Mineo Chrysa	Director	Jun 03 '25	Buy	23.44	1,050	24,614	3,320	Jun 04 04:23 PM
Ward Shane	COO & CLO	Mar 11 '25	Sale	21.96	1,664	36,542	14,674	Mar 13 06:34 PM
Tari Leslie	CHIEF SCIENTIFIC OFFICER	Mar 11 '25	Sale	21.96	1,773	38,940	16,215	Mar 13 06:33 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CDTX

Cidara Therapeutics Inc

Upgrade your FINVIZ experience